Detalles de la búsqueda
1.
Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer.
Mod Pathol
; 34(7): 1297-1309, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33558657
2.
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
Oncologist
; 24(2): 165-171, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171067
3.
Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
Eur J Surg Oncol
; 45(4): 550-559, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30454971
4.
Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer.
Clin Drug Investig
; 39(1): 113, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30637612
5.
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.
Transl Oncol
; 12(12): 1557-1565, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31513983
6.
Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer.
Clin Drug Investig
; 38(11): 1071-1075, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187361
Resultados
1 -
6
de 6
1
Próxima >
>>